Immunicum AB (publ) Interim Report January

What we doOur approachPipelineTechnology
About usManagementBoardClinical Advisory BoardCareers
NewsroomPress ReleasesEventsPatient Stories
Investors

Back
Immunicum AB (publ) Interim Report January – September 2020
 8:00:00 AM

Keep reading
Immunicum AB: Immunicum AB (publ) Announces ATMP Certificate Granted by EMA to Ilixadencel for Manufacturing Quality and Non-clinical DataRead